Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial
Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page
- Check4 days agoChange DetectedPublication record updated: the Walters et al. cost-effectiveness paper moved from May 2026 online-ahead-of-print to the final July 2026 print publication in the Publications section of the study page.SummaryDifference0.0%

- Check11 days agoChange DetectedThe study record now shows revision v3.6.3 for the study documents, replacing the previous v3.6.2; this reflects an updated version of the study protocol and related materials.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of Revision: v3.6.0. This reflects a small build or content update to the page.SummaryDifference0.0%

- Check33 days agoChange DetectedThe study details page now includes new help and navigation items such as 'No longer looking for participants', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and the heading 'Intervention/Treatment' is reformatted. The page also updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now lists Revision: v3.5.5 in the Study Protocol area, and Revision: v3.5.4 has been removed. This indicates an administrative update to the protocol document referenced on the page.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision update: the page version changes from v3.5.3 to v3.5.4. This represents a platform-level update with no substantive changes to study details or content on the page.SummaryDifference0.0%

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.